CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,743 | -9.7% | 20,290 | -0.0% | 0.01% | 0.0% |
| Q2 2023 | $662,023 | +119614.8% | 20,295 | +29.2% | 0.01% | +25.0% |
| Q1 2023 | $553 | -23.4% | 15,705 | -0.4% | 0.00% | -33.3% |
| Q4 2022 | $722 | -99.9% | 15,765 | -0.6% | 0.01% | 0.0% |
| Q3 2022 | $755,000 | +22.4% | 15,865 | +1.0% | 0.01% | +20.0% |
| Q2 2022 | $617,000 | +37.4% | 15,710 | +28.7% | 0.01% | +66.7% |
| Q1 2022 | $449,000 | -8.6% | 12,210 | -17.5% | 0.00% | -25.0% |
| Q4 2021 | $491,000 | +8.1% | 14,795 | +16.5% | 0.00% | +33.3% |
| Q3 2021 | $454,000 | +116.2% | 12,700 | +19.6% | 0.00% | +200.0% |
| Q2 2021 | $210,000 | -15.0% | 10,620 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $247,000 | +38.0% | 10,620 | +23.5% | 0.00% | +100.0% |
| Q4 2020 | $179,000 | -16.7% | 8,600 | -13.6% | 0.00% | -50.0% |
| Q3 2020 | $215,000 | +16.8% | 9,950 | +27.6% | 0.00% | 0.0% |
| Q2 2020 | $184,000 | +109.1% | 7,800 | +4.0% | 0.00% | +100.0% |
| Q1 2020 | $88,000 | +10.0% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $80,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |